Aizon
Aizon sells a cloud platform that combines real-time monitoring, predictive analytics, electronic batch records and agentic AI for drug and biotech manufacturing, aimed at regulated pharma and biotech producers. It was founded around 2014 under the name Bigfinite, later rebranded to Aizon, and sells software on a SaaS model from offices in San Francisco and Barcelona. Its notable funding includes a $20M Series C in February 2024 led by NewVale Capital, bringing reported total funding to roughly $45M, and a third-party database estimates 2024 revenue at about $14.6M.
Funding
Every round, secondary, debt facility or acquisition involving Aizon that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in